Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04089904
Title Phase II Trial of Neoadjuvant Pembrolizumab for Patients With Early Stage Gastroesophageal Adenocarcinoma
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors University of Chicago
Indications

gastroesophageal junction adenocarcinoma

esophagus adenocarcinoma

gastric adenocarcinoma

Therapies

Pembrolizumab

Age Groups: senior | adult
Covered Countries USA

Facility Status City State Zip Country Details
University Of Chicago Medicine Comprehensive Cancer Center Recruiting Chicago Illinois 60637 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field